Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice

Biochemical and Biophysical Research Communications

Volumn 444, Issue 4, 2014, Pages 622-627

  Wang, Liming ^a   Tang, Yuping ^a   Eisner, William ^a   Sparks, Matthew A ^a   Buckley, Anne F ^b   Spurney, Robert F ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Diabetic nephropathy; Podocyte

Indexed keywords

ALBUMIN; CREATININE; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GLUCOSE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL COUNT; CELL DAMAGE; CELL EXPANSION; CELL STRUCTURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FIBROSING ALVEOLITIS; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; HEART WEIGHT; HISTOPATHOLOGY; HYPERGLYCEMIA; KIDNEY MASS; MESANGIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; URINARY EXCRETION;

MUS;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; PODOCYTE;

ALBUMINURIA; ANIMALS; ANTIMETABOLITES; CYTOSINE DEAMINASE; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FLUCYTOSINE; FLUOROURACIL; GENE EXPRESSION; KIDNEY; MICE; PODOCYTES; PRODRUGS;

EID: 84894547921     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.115     Document Type: Article

References (35)

1. A.J. Collins, R.N. Foley, and B. Chavers et al. 'United States renal data system 2011 annual data report: Atlas of chronic kidney disease & end-stage renal disease in the United States Am. J. Kidney Dis. 59 A7 2012 e1 e420
2. E. Ritz, I. Rychlik, and F. Locatelli et al. Medicineal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions Am. J. Kidney Dis. 34 1999 795 808
3. R.A. Rodby Type II diabetic nephropathy: Its clinical course and therapeutic implications Semin. Nephrol. 17 1997 132 147
4. B.M. Brenner, M.E. Cooper, and D. de Zeeuw et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N. Engl. J. Med. 345 2001 861 869
5. E.J. Lewis, L.G. Hunsicker, and W.R. Clarke et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N. Engl. J. Med. 345 2001 851 860
6. G. Wolf, S. Chen, and F.N. Ziyadeh From the periphery of the glomerular capillary wall toward the center of disease: Podocyte injury comes of age in diabetic nephropathy Diabetes 54 2005 1626 1634
7. J.A. Jefferson, S.J. Shankland, and R.H. Pichler Proteinuria in diabetic kidney disease: A mechanistic viewpoint Kidney Int. 74 2008 22 36
8. R.C. Wiggins The spectrum of podocytopathies: A unifying view of glomerular diseases Kidney Int. 71 2007 1205 1214
9. M. Dalla Vestra, A. Masiero, and A.M. Roiter et al. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes Diabetes 52 2003 1031 1035
10. T.W. Meyer, P.H. Bennett, and R.G. Nelson Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria Diabetologia 42 1999 1341 1344
11. K.E. White, R.W. Bilous, and S.M. Marshall et al. Podocyte number in normotensive type 1 diabetic patients with albuminuria Diabetes 51 2002 3083 3089
12. W. Kriz, N. Gretz, and K.V. Lemley Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int. 54 1998 687 697
13. J.H. Chang, S.Y. Paik, and L. Mao et al. Diabetic kidney disease in FVB/NJ Akita mice: Temporal pattern of kidney injury and urinary nephrin excretion PLoS One 7 2012 e33942
14. L. Wang, Y. Tang, and D.N. Howell et al. A novel mouse model of podocyte depletion Nephron Exp. Nephrol. 121 2012 e10 e22
15. S.B. Gurley, S.E. Clare, and K.P. Snow et al. Impact of genetic background on nephropathy in diabetic mice Am. J. Physiol. Renal Physiol. 290 2006 F214 F222
16. S.B. Gurley, C.L. Mach, and J. Stegbauer et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice Am. J. Physiol. Renal Physiol. 298 2010 F788 F795
17. A. Vermes, H.J. Guchelaar, and J. Dankert Flucytosine: A review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions J. Antimicrob. Chemother. 46 2000 171 179
18. J.R. Gingrich, and J. Roder Inducible gene expression in the nervous system of transgenic mice Annu. Rev. Neurosci. 21 1998 377 405
19. T. Shigehara, C. Zaragoza, and C. Kitiyakara et al. Inducible podocyte-specific gene expression in transgenic mice J. Am. Soc. Nephrol. 14 2003 1998 2003
20. B. Najafian, Y. Kim, and J.T. Crosson et al. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy J. Am. Soc. Nephrol. 14 2003 908 917
21. S. Zheng, E.C. Carlson, and L. Yang et al. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy J. Am. Soc. Nephrol. 19 2008 2077 2085
22. P.L. St John, and D.R. Abrahamson Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains Kidney Int. 60 2001 1037 1046
23. H. Zhang, M. Schin, and J. Saha et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice Am. J. Physiol. Renal Physiol. 299 2010 F91 F98
24. A.A. Eddy Proteinuria and interstitial injury Nephrol. Dial Transplant. 19 2004 277 281
25. D. Schlondorff, and B. Banas The mesangial cell revisited: no cell is an island J. Am. Soc. Nephrol. 20 2009 1179 1187
26. C.N. Gamble The pathogenesis of hyaline arteriolosclerosis Am. J. Pathol. 122 1986 410 420
27. H. Anders, and D. Schlondorff Murine models of renal disease: Possibilities and problems in studies using mutant mice Exp. Nephrol. 8 2000 181 193
28. G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes Dev. 19 2005 1129 1155
29. M.D. Breyer, E. Bottinger, and F.C. Brosius 3rd et al. Mouse models of diabetic nephropathy J. Am. Soc. Nephrol. 16 2005 27 45
30. A.B. Fogo Animal models of FSGS: lessons for pathogenesis and treatment Semin. Nephrol. 23 2003 161 171
31. K. Susztak, A.C. Raff, and M. Schiffer et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy Diabetes 55 2006 225 233
32. D. Appel, D.B. Kershaw, and B. Smeets et al. Recruitment of podocytes from glomerular parietal epithelial cells J. Am. Soc. Nephrol. 20 2009 333 343
33. E. Ronconi, C. Sagrinati, and M.L. Angelotti et al. Regeneration of glomerular podocytes by human renal progenitors J. Am. Soc. Nephrol. 20 2009 322 332
34. C. Sagrinati, G.S. Netti, and B. Mazzinghi et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys J. Am. Soc. Nephrol. 17 2006 2443 2456
35. W. Pichaiwong, K.L. Hudkins, and T. Wietecha et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy J. Am. Soc. Nephrol. 24 2013 1088 1102